Alpha 2.0
Login Register
» Authors » Xinrong Zhan

Xinrong Zhan

Explore the profile of Xinrong Zhan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 28
Followers 0
Related Specialties
Hematology
General Surgery
Social Sciences
Top 10 Co-Authors
Xianjing Wang
Jian Zhou
Yanli Zhang
Yongping Song
Yingling Zu
Zhen Li
Ruirui Gui
Bo Cai
Zhongliang Wang
Mei Guo
Published In
Zhonghua Xue Ye Xue Za Zhi
Br J Haematol
Heliyon
Stem Cells Dev
Platelets
Affiliations
Soon will be listed here.
Recent Articles
1.
Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group
Ai H, Chao N, Rizzieri D, Huang X, Spitzer T, Wang J, et al.
Heliyon . 2023 Apr; 9(4):e14924. PMID: 37089296
Recent studies have shown that microtransplant (MST) could improve outcome of patients with elderly acute myeloid leukemia (EAML). To further standardize the MST therapy and improve outcomes in EAML patients,...
2.
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial
Zu Y, Gui R, Li Z, Wang J, Zhang Y, Yu F, et al.
Blood Cancer J . 2023 Jan; 13(1):10. PMID: 36631450
No abstract available.
3.
Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study
Liu X, Bai Y, Wang T, Song Y, Sun F, Xia R, et al.
Platelets . 2023 Jan; 34(1):2157806. PMID: 36597010
Recombinant human TPO (rhTPO) is effective for refractory/relapsed primary immune thrombocytopenia (ITP), but optimal dosing regimen remains elusive. In this multicenter, randomized, controlled trial, a total of 282 adult ITP...
4.
Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell...
Zhang W, Gui R, Zu Y, Zhang B, Li Z, Zhang Y, et al.
Br J Haematol . 2022 Oct; 200(2):210-221. PMID: 36200642
Anti-thymocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy)-based regimens are widely used for graft-versus-host disease (GVHD) prophylaxis in haploidentical haematopoietic stem cell transplantation (haplo-HSCT). To improve the effectiveness of GVHD prophylaxis...
5.
Low-dose post-transplant cyclophosphamide with low-dose antithymocyte globulin for prevention of graft-versus-host disease in first complete remission undergoing 10/10 HLA-matched unrelated donor peripheral blood stem cell transplants: a...
Zu Y, Li Z, Gui R, Liu Y, Zhang Y, Yu F, et al.
Bone Marrow Transplant . 2022 Jul; 57(10):1573-1580. PMID: 35840747
The most widely used regimens of graft-versus-host disease (GVHD) prophylaxis in HLA-matched unrelated donor peripheral blood stem cell transplantation (MUD-PBSCT) are based on anti-thymocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy)....
6.
Donor Selection in HLA-Mismatched Hematopoietic Stem Cell Microtransplantation for Acute Myeloid Leukemia
Hu K, Ai H, Guo M, Yu C, Qiao J, Sun Q, et al.
Stem Cells Dev . 2020 Mar; 29(10):648-654. PMID: 32122266
To remedy the lack of human leukocyte antigen (HLA)-matched donors and address the problems bedeviling traditional allogeneic hematopoietic stem cell transplantation which induces the resultant graft-versus-host disease, we designed a...
7.
[Efficacy analysis of cyclosporine in treatment of trisomy 8 myelodysplastic syndrome]
Wang Y, Wang Q, Zhan X, Hu J, Wei X
Zhonghua Xue Ye Xue Za Zhi . 2014 Mar; 35(1):61-2. PMID: 24602737
No abstract available.